Agaricus sylvaticus mantarının besin takviyesi olarak kemoterapi gören meme kanserli hastaların hematolojik ve bağışıklık sistemine etkisi
Amaç: Kanser hastaları hastalığın seyri sırasında immünolojik ve hematolojik değişimler gelişmesine eğilimlidir. Tıbbi mantarlar, prognozda iyileşme ve fizyolojik yanıtı artırıcı etkiyle bağışıklık ve hematopoetik sistemleri uyarabilirler. Bu çalışmada Agaricus sylvaticus ile besin takviyesi sonrası kemoterapi gören meme kanserli hastalardaki hematolojik ve immünolojik parametrelerin değerlendirilmesi amaçlanmıştır. Yöntem: Randomize seçilmiş, çift-kör, plasebo kontrollü bir çalışma uygulanmıştır. 46 hastaya grup II ve III rastgele olarak ya plasebo ya da besin kaynağı olarak A. sylvaticus 2,1 g/gün verilmiştir. Hastalara 3 doz n=26 ve 6 doz kemoterapi uygulanmış, klinik ve laboratuvar değerlendirmeleri yapılmıştır. Çalışma sonuçları Microsoft Excel 2003 ve R-version 2.11.1 kullanılarak analiz edilmiş ve p
Effect of dietary supplementation with Agaricus sylvaticus fungus on the hematology and immunology systems of breast cancer patients undergoing chemotherapy
Objective: Patients with cancer tend to develop hematological and immunological alterations during the disease process. Medicinal fungi can stimulate the immune and hematopoietic systems, promoting improvements in the prognosis and physiological response. In this trial it is aimed to evaluate changes in hematological and immunological parameters in patients with breast cancer undergoing chemotherapy after dietary supplementation with Agaricus sylvaticus. Method: A randomized, double-blind, placebocontrolled study was carried out. 46 patients stadiums II and III , were randomly assigned to receive either: nutritional supplement with A. sylvaticus 2.1 g/day or placebo. Patients received three cycles n=26 and six cycles n=20 of chemotherapy. Clinical and laboratory evaluations were performed. The results were analyzed using Microsoft Excel 2003 and R-version 2.11.1, significant results at p≤ 0.05. Results: The A. sylvaticus group showed an increase of hematocrits p=0.04 , red blood count p=0.03 , mean corpuscular hemoglobin concentration p=0.001 , leukocytes p=0.03 , monocytes p=0.001 , and total lymphocyte count p=0.009 after three months. Those changes were not observed in the placebo group. After six months, patients receiving A. sylvaticus showed increased levels of red blood count p=0.02 , hemoglobin p=0.02 , hematocrits p=0.02 , corpuscular hemoglobin concentration p=0.02 , leukocytes p=0.02 ; lymphocytes p=0.02 , neutrophils p=0.02 and TLC p=0.02 . The placebo group showed a reduction in leukocytes p=0.004 , basophiles p=0.005 and TLC p=0.01 . Conclusion: The results suggest the usefulness of dietary supplementation with A. sylvaticus in patients with breast cancer undergoing chemotherapy.
___
- 1. Brazil. Ministério da Saúde. Secretaria Nacional de
Assistência à Saúde. Instituto Nacional do Câncer
[INCA]. Estimate 2010: Cancer Incidence in Brazil.
Rio de Janeiro: INCA 2009. Brazil.
- 2. Tiezzi DG. Epidemiology of breast cancer. Rev Bras
Obstetr Ginecol. 2009; 3(5): 213-5.
- 3. Guerra MR, Gallo CVM, Mendonça GAS. Risk of
cancer in Brazil: trends and recent epidemiological
studies. Rev Cancer Brazil, 2005; 51(3):227- 34.
- 4. Brazil. Ministério da Saúde. Instituto Nacional do
Câncer [INCA]. Control of Breast Cancer: Consensus
Document. Rio de Janeiro: INCA 2004.
- 5. Brito C, Portela MC, Vasconcellos MTL. SUS
oncological care to women with breast cancer in
Rio de Janeiro. Rev Public Health, 2005; 39(6):
874- 81.
- 6. Brito C, Portela MC, Vasconcellos MTL. Survival of
women treated for breast cancer in Rio de Janeiro.
Rev S Pub, 2009; 43(3): 481-9.
- 7. Shang EC, Weiss PS, Kaehler G. The Influence of
early supplementation of parenteral on nutrition
quality of life and body composition in patients
with advanced cancer. J Par Ent Nutr, 2006; 30(3):
222-30.
- 8. Giglio A. A quimioterapia adjuvante para cancer de
mama engorda? Rev Assoc Med Bras, 2004; 50(3):
238-45.
- 9. Giglio A. A quimioterapia adjuvante para câncer de
mama engorda? Rev Assoc Med Bras, 2004; 50(3):
32-9.
- 10. Neugut AI, Matthew M, Xiaoyan W, Russell M,
Jacobson JS, Wei-Yann T, Grann VR, Dawn LH.
Duration of adjuvant chemotherapy for colon
cancer and survival among the elderly. J Clin Oncol,
2006; 24(15): 2368-75.
- 11. Perez E, Muss HB. Optimizing adjuvant
chemotherapy in early-stage of breast cancer.
Oncology, 2005; 19(4): 1759-67.
- 12. Novaes MRCG, Fortes RC. Antitumor effects of
edible Agaricaceae mushrooms. Nutrition Brazil,
2005; 4(4): 15-9.
- 13. Novaes MRCG, Novaes LCG. Drug-nutrient in edible
mushrooms and other basidiomycetous Agaricales.
Rev Bras Nutr Clin, 2005; 20(3): 181-7.
- 14. Fortes RC, Novaes MRCG. Effects of dietary
supplementation with Agaricales mushrooms and
other fungi in medicinal therapy against cancer.
RBC, 2006; 52(4): 363-71.
- 15. Novaes MRCG, Fortes R, Melo A, Recova V.
Alterations on the metabolism of lipids in postsurgery patients suffering from colorectal cancer
supplemented with Agaricus sylvaticus fungus.
Proceedings of the 27th International Congress
of ESPEN and Clinical Nutrition. August, 27-30,
Brussels, Belgium. 2005.
- 16. Novaes MRCG, Novaes LCG, Recova V, Melo A.
Evalution of acute toxicity of edible mushroom
Agaricus sylvaticus. Proceedings of the 27th
International Congress of ESPEN and Clinical
Nutrition. August, 27-30, Brussels, Belgium. 2005.
- 17. Novaes MRG, Novaes Garcez LCG, Melo A, Recova
V. Effects of administration of Agaricus sylvaticus
fungi on hematological and immunological systems
of rats with Walker carcinoma-256. Fundamental &
Clinical Pharmacology, 2004; 18 (S1): 125-9.
- 18. Takimoto HD, Wakita KK, Kumazawa Y. Potentiation
of cytotoxic activity in naive and tumor-bearing
mice by oral administration of hot-water extracts
from Agaricus braze f ruiting bodies. Biol Pharm
Bull, 2004; 27: 404-6.
- 19. Chu KKW, Ho SSS, Chow AHL. Coriolus versicolor:
a medicinal mushroom with promising
immunotherapeutic values. J Clin Pharmacol, 2002;
42: 976-84.
- 20. Soh CSR, Phung HS, Ye JJ, Kwok SL, Shroder GE,
Belury M, Adams LS. Williams D. Anti-aromatase
activity of phytochemicals in white button
mushrooms (Agaricus bisporus). Cancer Res, 2006;
66: 12026-34.
- 21. Grube JB, Eng ET, Kao YC, Kwon A, Chen S. White
button mushroom phytochemicals inhibit aromatase
activity and breast cancer cell proliferation. J Nutr,
2001; 131: 3288-93.
- 22. Shang EC, Weiss PS, Kaehler G. The influence of
early supplementation of parenteral on nutrition
quality of life and body composition in patients
with advanced cancer. J Par Ent Nut, 2006; 30(3):
222-30.
- 23. Fang N, Li Q, Yu S, Zhang J, He L, Ronis MJ,
Badger TM. Inhibition of growth and induction of
apoptosis in human cancer cell lines by an ethyl
acetate fraction from shiitake mushrooms. J Altern
Complement Med, 2006; 12(2): 125-32.
- 24. Takaku T, Kimura Y, Okuda H. Isolation of an
antitumor compound from Agaricus blazei Murill
and Its mechanism of action. Journal of Nutrition,
2001; 131: 1409-13.
- 25. Jedinak A, Sliva D. Pleorotus ostreatus inhibits
proliferation of human breast cancer and colon
cancer cells through p53-dependent as well as p53-
independent pathway. Inter J Oncol, 2008; 33(6):
1307-13.
- 26. Hetland G, Johnson E, Lyberg T, Bernardshaw S,
Tryggestad AM, Grinde B. Effects of the medicinal
mushroom Agaricus blazei Murill on immunity,
infection and cancer. Scand J Immunol, 2008;
68(4): 363-70.
- 27. Ajith TA, Janardhanan KK. Indian Medicinal
Mushrooms as a source of antioxidant and antitumor
agents. J Clin Biochem Nutr, 2007; 40(3): 157-62.
- 28. Bernadshaw S, Lyberg T, Hetland G, Johnson E.
Effect of an extract of the mushroom Agaricus
blazei Murill on expression of adhesion molecule
and production of reactive oxygen species in
monocytes and granulocytes in human whole blood
ex vivo. APMIS. 2007; 115(6): 719-25.
- 29. Talorete TP, Isoda H, Maekawa T. Agaricus blazei
(class Basidiomycotina) aqueous extract enhances
the expression of c-Jun protein in MCF-7 cells. J
Agric Food Chem. 2002; 50(18): 5162-6.
- 30. Hong SA, Kim K, Nam SJ, Kong G, Kim MKA casecontrol study on the dietary intake of mushrooms
and breast cancer risk among Korean women. Int J
Cancer. 2008; 122(4th): 919-23.
- 31. Fortes RC, Novaes MRCG. The impact of dietary
supplementation with Agaricus sylvaticus on
immune function of post-surgical patients suffering
from colorectal cancer: a randomized, double
blind, placebo-controlled clinical trial. Proceedings
of the I. World Congress of Public Health Nutrition
/ VII National Congress of the Spanish Society of
Community Nutrition. Public Health Nutrition,
28- 30 September 2006, Barcelona, Spain:
NS 2006.
- 32. Dolby V. In maitake mushroom extract froom is
important in anti-cancer. Better Nutrition. 1997;
59(8): 38.
- 33. See D. Mason St. Roshan R. Increased tumor
necrosis factor alpha (TNF-alpha) and natural killer
cell (NK) function using an integrative approach
in late stage cancers. Immunol Invest. 2002; 31:
137-53.
- 34. Gennari J, Gennari M, Felippe J. The Agaricus
sylvaticus increases the number of natural killer
cells in cancer patients. J Com Med. 2001; 7:
42-5.
- 35. Gennari JL,Veronesi R, Gennari M. Use of Agaricus
sylvaticus as a supplement therapy in patients
with breast cancer and lung metastasis. Revista
Brasileira de Medicina. 2002; 59(7): 237-8.
- 36. Aguiar MRS. Impact of Food Supplementation on
Hematologic Toxicity And Quality of Life and Women
with Breast Cancer under Adjuvant Chemotherapy
Regimen. Thesis [Master's Degree - Science and
Environmental Health] Catholic University of Goiás,
2008.
- 37. Padilha MM, Avila AA, Sousa PJ, Cardoso LG,
Perazzo FF, Carvalho JC. Anti-inflammatory activity
of aqueous and alkaline extracts from mushrooms
(Agaricus blazei Murill). J Med Food. 2009; 12(2):
59-64.